Sensus Healthcare, Inc. (SRTS)
SRTS Stock Price Chart
Explore Sensus Healthcare, Inc. interactive price chart. Choose custom timeframes to analyze SRTS price movements and trends.
SRTS Company Profile
Discover essential business fundamentals and corporate details for Sensus Healthcare, Inc. (SRTS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
26 Jul 2016
Employees
54.00
Website
https://www.sensushealthcare.comCEO
Joseph C. Sardano
Description
Sensus Healthcare, Inc. operates as a medical technology enterprise, manufacturing and distributing radiation therapy apparatuses to medical institutions across the globe. The company's portfolio leverages superficial radiation therapy (SRT), a cutting-edge low-energy X-ray methodology. Their product line features the SRT-100, a photon X-ray system for low-energy superficial radiotherapy. This device presents a non-surgical alternative for patients dealing with non-melanoma skin cancers, including basal cell and squamous cell carcinomas, alongside other dermatological issues like keloids. Another key offering is the SRT-100 Vision, which incorporates a specialized SRT treatment planning application. This application seamlessly integrates an embedded high-frequency ultrasound imaging module, tools for volumetric tumor analysis, beam margin delineation, and dosimetry parameter configuration. In addition, Sensus Healthcare provides the SRT-100 Plus, the Sentinel service program to ensure system protection for its clients, and options for in-office laser rentals. They also supply various consumable items, such as replacement lead shielding, disposable radiation safety gear like aprons and eye shields, ultrasound probe film, and single-use applicator tips designed to treat lesions of different sizes and on various body areas. Founded in 2010, Sensus Healthcare, Inc. maintains its corporate headquarters in Boca Raton, Florida.
SRTS Financial Timeline
Browse a chronological timeline of Sensus Healthcare, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is -$0.13, while revenue estimate is $4.60m.
Earnings released on 7 May 2026
EPS came in at -$0.16 falling short of the estimated -$0.13 by -28.00%, while revenue for the quarter reached $3.39m , missing expectations by -36.24%.
Earnings released on 12 Feb 2026
EPS came in at -$0.19 falling short of the estimated -$0.06 by -245.45%, while revenue for the quarter reached $4.94m , missing expectations by -40.81%.
Earnings released on 6 Nov 2025
EPS came in at -$0.06 surpassing the estimated -$0.11 by +45.45%, while revenue for the quarter reached $6.88m , beating expectations by +9.05%.
Earnings released on 7 Aug 2025
EPS came in at -$0.06 falling short of the estimated $0.01 by -700.00%, while revenue for the quarter reached $7.32m , beating expectations by +15.88%.
Earnings released on 15 May 2025
EPS came in at -$0.16 falling short of the estimated $0.04 by -500.00%, while revenue for the quarter reached $8.34m , beating expectations by +15.34%.
Earnings released on 5 Feb 2025
EPS came in at $0.09 falling short of the estimated $0.10 by -10.00%, while revenue for the quarter reached $13.07m , beating expectations by +105.61%.
Earnings released on 14 Nov 2024
EPS came in at $0.07 surpassing the estimated $0.01 by +799.74%, while revenue for the quarter reached $8.84m , beating expectations by +49.93%.
Earnings released on 8 Aug 2024
EPS came in at $0.10 surpassing the estimated $0.02 by +328.63%, while revenue for the quarter reached $9.24m , beating expectations by +31.99%.
Earnings released on 9 May 2024
EPS came in at $0.14 surpassing the estimated -$0.05 by +380.00%, while revenue for the quarter reached $10.66m , beating expectations by +158.81%.
Earnings released on 8 Feb 2024
EPS came in at $0.26 surpassing the estimated $0.12 by +116.67%, while revenue for the quarter reached $12.57m , beating expectations by +13.62%.
Earnings released on 9 Nov 2023
EPS came in at -$0.09 falling short of the estimated -$0.02 by -400.00%, while revenue for the quarter reached $3.90m , missing expectations by -33.94%.
Earnings released on 3 Aug 2023
EPS came in at -$0.02 surpassing the estimated -$0.05 by +60.00%, while revenue for the quarter reached $4.53m , missing expectations by -0.51%.
Earnings released on 3 May 2023
EPS came in at -$0.12 falling short of the estimated $0.11 by -209.09%, while revenue for the quarter reached $3.41m , missing expectations by -66.30%.
Earnings released on 9 Feb 2023
EPS came in at $0.17 falling short of the estimated $0.23 by -26.09%, while revenue for the quarter reached $13.11m , beating expectations by +1.00%.
Earnings released on 3 Nov 2022
EPS came in at $0.11 falling short of the estimated $0.13 by -15.38%, while revenue for the quarter reached $9.01m , missing expectations by -5.54%.
Earnings released on 4 Aug 2022
EPS came in at $0.21 surpassing the estimated $0.13 by +61.54%, while revenue for the quarter reached $12.08m , beating expectations by +26.42%.
Earnings released on 5 May 2022
EPS came in at $0.20 surpassing the estimated $0.06 by +233.33%, while revenue for the quarter reached $10.34m , beating expectations by +53.55%.
Earnings released on 10 Feb 2022
EPS came in at $0.32 surpassing the estimated $0.16 by +100.00%, while revenue for the quarter reached $13.03m , beating expectations by +17.53%.
Earnings released on 4 Nov 2021
EPS came in at $0.01 surpassing the estimated $0.00 by +159.74%, while revenue for the quarter reached $5.53m , missing expectations by -0.81%.
Earnings released on 5 Aug 2021
EPS came in at -$0.02 surpassing the estimated -$0.05 by +60.00%, while revenue for the quarter reached $5.42m , meeting expectations.
SRTS Stock Performance
Access detailed SRTS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
